Statins
Sort by:
MUSC Cardiology
MASH, MASLD, MetALD: New Names, New Insights in Liver Disease
FEATURING
Andrew Schreiner
- 1,297 views
- March 26, 2024
- 3
National Lipid Association
Bempedoic Acid: Mechanism of Action, Effects and Potential Uses
FEATURING
Anne Goldberg
- 842 views
- March 19, 2020
- 3
Houston Methodist DeBakey Heart and Vascular Center
Current and Emerging Options in Lipid Management
FEATURING
Raul Santos
- 565 views
- October 20, 2021
- 3
The Texas Heart Institute
Inside the Studio with Drs. Joseph Rogers and Salim Virani - Current Status of Lipid Management
FEATURING
Joseph Rogers,
Salim Virani
- 119 views
- January 5, 2023
- 3
Advances in Cardiovascular Disease Prevention
Comprehensive Lifestyle Changes Provide an Alternative
FEATURING
Dean Ornish
- 633 views
- October 22, 2018
- 3
Cardiometabolic Health Congress (CMHC)
Triglycerides and Cardiovascular Disease
- 435 views
- January 10, 2019
- 3
The North American Thrombosis Forum (NATF)
The Critical Importance of Lowering LDL-C in High-Risk Patients
- 423 views
- January 26, 2023
- 3
National Lipid Association
Lipids Clinic Management in Private Practice Setting
FEATURING
Ann Liebeskind
- 377 views
- March 25, 2019
- 3
National Lipid Association
Comparison 2013 and 2018 Cholesterol Guidelines in Primary Prevention
FEATURING
Neil Stone
- 746 views
- March 25, 2019
- 3
Cardiometabolic Health Congress (CMHC)
2020 Update on Lipid Lowering Therapy in ASCD: What Medications Are Available to Address Residual Risk of in Statin Treated Patients? What Do the Treatment Guidelines Define as High-Risk Patients in Primary Prevention?
FEATURING
Salim Virani
- 896 views
- September 22, 2020
- 3
National Lipid Association
Treatments for Maximizing Prevention of Microvascular Complications
FEATURING
Leah Wilson
- 411 views
- March 25, 2019
- 3
Complex Coronary Cases
The Latest in Managing Comorbidities in Complex PCI: LDL-C and Lp(a)
FEATURING
Marc Bonaca
- 277 views
- July 23, 2024
- 3
The American Society for Preventive Cardiology
Recommendations for Secondary ASCVD Prevention and Non-statin Drug Use
FEATURING
Salim Virani
- 752 views
- January 23, 2019
- 3
Northwestern Medicine: 8th Annual Cardiovascular Update
What's New and Why- Cholesterol Guidelines
FEATURING
Neil Stone
- 423 views
- August 14, 2019
- 3
New Cardiovascular Horizons (NCVH) 2017
Role of Statins and PCSK9 Inhibitors
FEATURING
Craig Walker
- 566 views
- September 18, 2017
- 2
Cardiology Pulse 2019
Top 5 Cardiovascular Prevention Trials
FEATURING
Robert Chilton
- 267 views
- October 30, 2019
- 3
Cardiovascular Atherosclerosis: Prediction, Prevention and Management
Update on Inflammation and Novel Biomarkers for Atherosclerosis
FEATURING
Douglas Triffon
- 382 views
- August 11, 2021
- 2
UPMC
Risky Business – Accurately Assessing Cardiac Risk and Acting Accordingly
FEATURING
Eric Dueweke
- 202 views
- July 5, 2024
- 2
25th Annual San Diego Heart Failure Symposium
What’s New in Treating Hyperlipidemia: Update on PCSK9 Inhibition and Treating Hypertriglyceridemia
FEATURING
Pam Taub
- 321 views
- August 8, 2019
- 2
Canadian Collaborative Research Network
A Practical Approach to LDL and TG-Related Risk Management
FEATURING
Robert Hegele
- 689 views
- August 13, 2024
- 2